{"id":{"repo_id":"msu","oai_identifier":"oai:d.lib.msu.edu:etd_53206"},"canonical_url":"https://search.ndltd.org/etd/msu/oai:d.lib.msu.edu:etd_53206","repository":{"repo_id":"msu","name":"Michigan State University","base_url":"https://d.lib.msu.edu/oai"},"display":{"title":"Next-Generation Vaccine Design : Synthetic Carbohydrate and Virus-Like Particle Platforms Targeting Infectious and Neurodegenerative Diseases","abstract":"Thesis (Ph.D.)--Michigan State University. Chemistry - Doctor of Philosophy, 2026","abstract_html":"Thesis (Ph.D.)--Michigan State University. Chemistry - Doctor of Philosophy, 2026","abstract_has_math":false,"creators":["Talbot, Cameron"],"institution":null,"degree_name":null,"degree_level":null,"degree_discipline":null,"degree_department":null,"school":null,"contributors":["Huang, Xuefei","Tepe, Jetze","Hu, Jian","Geiger, James"],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2026,"date_issued":"2026","date_published":"2026","updated_at":"2026-11-18T18:59:44Z","subjects":["Organic chemistry","Chemistry, Organic"],"languages":["eng"],"rights":["In Copyright"],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier","label":"Identifier","values":["etd:53206","local:Talbot_grad.msu_0128D_22235"],"render_values":[{"text":"etd:53206","href":null,"code":true},{"text":"local:Talbot_grad.msu_0128D_22235","href":null,"code":true}]}],"person_identifier_entries":[]},"links":{"outbound_url":"https://doi.org/doi:10.25335/2ssw-db43","outbound_label":"DOI","outbound_source":"dc:identifier","record_url":"https://doi.org/doi:10.25335/2ssw-db43","record_label":"Repository record","record_kind":"doi","record_source":"dc:identifier","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://d.lib.msu.edu/oai?verb=GetRecord&metadataPrefix=oai_dc&identifier=oai%3Ad.lib.msu.edu%3Aetd_53206","prefix":"oai_dc"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Huang, Xuefei","Tepe, Jetze","Hu, Jian","Geiger, James"]},{"key":"dc:creator","label":"Author","values":["Talbot, Cameron"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2026"]},{"key":"dc:relation","label":"Dc Relation","values":["Electronic Theses & Dissertations"]},{"key":"dc:type","label":"Dc Type","values":["text","Electronic dissertations"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Organic chemistry","Chemistry, Organic"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["eng"]},{"key":"dc:rights","label":"Dc Rights","values":["In Copyright"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["etd:53206","local:Talbot_grad.msu_0128D_22235","https://doi.org/doi:10.25335/2ssw-db43"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["Thesis (Ph.D.)--Michigan State University. Chemistry - Doctor of Philosophy, 2026","Salmonella infections remain a significant global health challenge, underscoring the need for vaccine strategies capable of providing broad and durable protection. Advances in vaccine development have increasingly focused on structurally defined carbohydrate antigens that target surface-exposed polysaccharides such as O-antigens and capsular polysaccharides, which play key roles in immune recognition and bacterial virulence. Recent progress in synthetic glycan chemistry has enabled the preparation of well-defined oligosaccharides that better mimic native antigen structures, allowing improved control over antigen presentation and immune specificity. Emerging carrier platforms, including virus-like particles, membrane-derived vesicles, and modular antigen display systems, have demonstrated the ability to enhance both antibody responses and cellular immunity. Collectively, these developments highlight the importance of integrating precise chemical design with immunological insight to guide the development of next-generation Salmonella vaccines.To explore the versatility of virus-like particle platforms beyond bacterial targets, bacteriophage Qβ virus-like particles were investigated as carriers for peptide-based vaccination against tau protein associated with neurodegenerative disease. A tau-derived peptide epitope was conjugated to Qβ particles to generate a multivalent construct designed to enhance immune recognition and antibody production. Immunization studies demonstrated strong anti-tau antibody responses, confirming that the Qβ platform effectively presents peptide antigens in a highly immunogenic format. Sustained antibody levels following booster immunizations indicated that the construct supported durable humoral responses over time. These findings demonstrate the flexibility of virus-like particle systems as adaptable carriers for vaccine development across multiple disease targets. Dual-function vaccine constructs were developed to promote both antibody-mediated and T cell–mediated immune responses against conserved Salmonella antigens. Dextran nanoparticle and modified Qβ virus-like particle platforms were engineered to display T cell epitopes derived from the Salmonella type III secretion system while maintaining compatibility with carbohydrate-based antigen presentation strategies. Immunization studies demonstrated strong antigen-specific antibody responses together with significant activation of CD4+ and CD8+ T cells, as evidenced by increased interferon-γ production following peptide restimulation. Vaccinated mice showed improved survival following bacterial challenge and significantly reduced bacterial burdens in both spleen and liver tissues, indicating enhanced control of systemic infection. These findings support the potential of multivalent vaccine platforms to generate coordinated humoral and cellular immune responses against invasive Salmonella infection.","Description based on online resource. Title from PDF t.p. (Michigan State University Fedora Repository, viewed ).","Includes bibliographical references."]},{"key":"dc:format","label":"Dc Format","values":["application/pdf","1 online resource (203 p.) : ill."]},{"key":"dc:title","label":"Title","values":["Next-Generation Vaccine Design : Synthetic Carbohydrate and Virus-Like Particle Platforms Targeting Infectious and Neurodegenerative Diseases"]}]}],"canonical_facts":{"dc:contributor":["Huang, Xuefei","Tepe, Jetze","Hu, Jian","Geiger, James"],"dc:creator":["Talbot, Cameron"],"dc:date":["2026"],"dc:description":["Thesis (Ph.D.)--Michigan State University. Chemistry - Doctor of Philosophy, 2026","Salmonella infections remain a significant global health challenge, underscoring the need for vaccine strategies capable of providing broad and durable protection. Advances in vaccine development have increasingly focused on structurally defined carbohydrate antigens that target surface-exposed polysaccharides such as O-antigens and capsular polysaccharides, which play key roles in immune recognition and bacterial virulence. Recent progress in synthetic glycan chemistry has enabled the preparation of well-defined oligosaccharides that better mimic native antigen structures, allowing improved control over antigen presentation and immune specificity. Emerging carrier platforms, including virus-like particles, membrane-derived vesicles, and modular antigen display systems, have demonstrated the ability to enhance both antibody responses and cellular immunity. Collectively, these developments highlight the importance of integrating precise chemical design with immunological insight to guide the development of next-generation Salmonella vaccines.To explore the versatility of virus-like particle platforms beyond bacterial targets, bacteriophage Qβ virus-like particles were investigated as carriers for peptide-based vaccination against tau protein associated with neurodegenerative disease. A tau-derived peptide epitope was conjugated to Qβ particles to generate a multivalent construct designed to enhance immune recognition and antibody production. Immunization studies demonstrated strong anti-tau antibody responses, confirming that the Qβ platform effectively presents peptide antigens in a highly immunogenic format. Sustained antibody levels following booster immunizations indicated that the construct supported durable humoral responses over time. These findings demonstrate the flexibility of virus-like particle systems as adaptable carriers for vaccine development across multiple disease targets. Dual-function vaccine constructs were developed to promote both antibody-mediated and T cell–mediated immune responses against conserved Salmonella antigens. Dextran nanoparticle and modified Qβ virus-like particle platforms were engineered to display T cell epitopes derived from the Salmonella type III secretion system while maintaining compatibility with carbohydrate-based antigen presentation strategies. Immunization studies demonstrated strong antigen-specific antibody responses together with significant activation of CD4+ and CD8+ T cells, as evidenced by increased interferon-γ production following peptide restimulation. Vaccinated mice showed improved survival following bacterial challenge and significantly reduced bacterial burdens in both spleen and liver tissues, indicating enhanced control of systemic infection. These findings support the potential of multivalent vaccine platforms to generate coordinated humoral and cellular immune responses against invasive Salmonella infection.","Description based on online resource. Title from PDF t.p. (Michigan State University Fedora Repository, viewed ).","Includes bibliographical references."],"dc:format":["application/pdf","1 online resource (203 p.) : ill."],"dc:identifier":["etd:53206","local:Talbot_grad.msu_0128D_22235","https://doi.org/doi:10.25335/2ssw-db43"],"dc:language":["eng"],"dc:relation":["Electronic Theses & Dissertations"],"dc:rights":["In Copyright"],"dc:subject":["Organic chemistry","Chemistry, Organic"],"dc:title":["Next-Generation Vaccine Design : Synthetic Carbohydrate and Virus-Like Particle Platforms Targeting Infectious and Neurodegenerative Diseases"],"dc:type":["text","Electronic dissertations"]},"updated_at":"2026-11-18T18:59:44Z"}